 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Tenet Healthcare (THC) is an investor-owned health care services company. It owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States.
The companys general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive care, critical care and/or coronary care units, physical therapy; and orthopedic, oncology, and outpatient services; tertiary care services, such as open-heart surgery, neonatal intensive care, and neuroscience; quaternary care in areas, including heart, liver, kidney, and bone marrow transplants, as well as burn services; gamma-knife brain surgery; and cyberknife radiation therapy for tumors and lesions in the brain, lung, neck, and spine.
In addition, the company offers operational management for patient access, health information management, revenue integrity, and patient financial services; customized patient communications solutions to optimize the relationship between providers and patients; and management services, such as clinical integration, financial risk management, and population health management.
Shares have formed a bullish "flag" following the release of its quarterly results and higher prices are expected for this stock.
We are now hearing rumors of good news for this company. One of the rumors states that this stock will be named by the leading stock advisory service as one of its "top picks." This service is widely followed by mutual funds and institutional money managers. These investors have portfolios that mimic recommendations of this service. Their naming of the stock should lead to additional demand for the shares.
52-Week Trading Range: $17.24 - $49.13
Entry Point: $47.50
Stop Loss: $45.10
Target Price: $52.25
THC fell below our stop loss. The position was closed at $44.75.
